Tag: tsxv:rx

March 20, 2019

BioSyent Releases Results for Fourth Quarter and Full Year 2018

BioSyent (TSXV:RX) has announced its financial results for the three and 12 month period ended December 31, 2018. As quoted...
November 21, 2018

BioSyent’s Share Price Drops on Q3 Earnings

Rene Geohrum, CEO of BioSyent, said the decrease in international revenue was the result of “restrictions in a particular export...
November 21, 2018

BioSyent Releases Results for Third Quarter and First Nine Months of 2018

BioSyent (TSXV:RX) released today a summary of its financial results for the three and nine months ended September 30, 2018....